Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label studyLijuan Deng, Jun Zhu, Zhenqian Huang et al.|American Journal of Hematology|2023Cited by 18
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCDLu Zhang, Li J, Qinhua Liu et al.|Blood Advances|2024Cited by 6
[Analysis of Clinical Pathological Features and Prognosis in Young Patients with Diffuse Large B Cell Lymphoma].Shu Fang, Chunji Gao, Shasha Zhao et al.|PubMed|2019Cited by 2
Haploidentical, Unmanipulated Granulocyte Colony-Stimulating Factor (G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia (AML) in Remission: A Single Center ExperienceLan Luo, Chunji Gao, Shu Fang et al.|Annals of Transplantation|2019Cited by 1
[Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies].Tao Lin, Chunji Gao, Shu Fang et al.|PubMed|2020Cited by 0